16339289

Source:http://linkedlifedata.com/resource/pubmed/id/16339289

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0029458, umls-concept:C0231435, umls-concept:C0379199, umls-concept:C0439234, umls-concept:C0442027, umls-concept:C1274040, umls-concept:C2603343
pubmed:issue	5
pubmed:dateCreated	2006-4-13
pubmed:abstractText	Reducing bisphosphonate dosing frequency may improve suboptimal adherence to treatment and therefore therapeutic outcomes in postmenopausal osteoporosis. Once-monthly oral ibandronate has been developed to overcome this problem.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/16339289, http://linkedlifedata.com/resource/pubmed/commentcorrection/16339289-10527181, http://linkedlifedata.com/resource/pubmed/commentcorrection/16339289-10634392, http://linkedlifedata.com/resource/pubmed/commentcorrection/16339289-10663363, http://linkedlifedata.com/resource/pubmed/commentcorrection/16339289-11558866, http://linkedlifedata.com/resource/pubmed/commentcorrection/16339289-11932287, http://linkedlifedata.com/resource/pubmed/commentcorrection/16339289-12817771, http://linkedlifedata.com/resource/pubmed/commentcorrection/16339289-1414493, http://linkedlifedata.com/resource/pubmed/commentcorrection/16339289-14584889, http://linkedlifedata.com/resource/pubmed/commentcorrection/16339289-15028823, http://linkedlifedata.com/resource/pubmed/commentcorrection/16339289-15050889, http://linkedlifedata.com/resource/pubmed/commentcorrection/16339289-15071723, http://linkedlifedata.com/resource/pubmed/commentcorrection/16339289-15167989, http://linkedlifedata.com/resource/pubmed/commentcorrection/16339289-15205712, http://linkedlifedata.com/resource/pubmed/commentcorrection/16339289-15231010, http://linkedlifedata.com/resource/pubmed/commentcorrection/16339289-15455188, http://linkedlifedata.com/resource/pubmed/commentcorrection/16339289-15972582, http://linkedlifedata.com/resource/pubmed/commentcorrection/16339289-16007327, http://linkedlifedata.com/resource/pubmed/commentcorrection/16339289-1838661, http://linkedlifedata.com/resource/pubmed/commentcorrection/16339289-8950879
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0372355
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Bone Density Conservation Agents, http://linkedlifedata.com/resource/pubmed/chemical/Diphosphonates, http://linkedlifedata.com/resource/pubmed/chemical/ibandronic acid
pubmed:status	MEDLINE
pubmed:month	May
pubmed:issn	0003-4967
pubmed:author	pubmed-author:AdamiSS, pubmed-author:BonvoisinBB, pubmed-author:ChristiansenCC, pubmed-author:CooperCC, pubmed-author:DelmasP DPD, pubmed-author:DreznerM KMK, pubmed-author:EmkeyRR, pubmed-author:FelsenbergDD, pubmed-author:GreenwaldMM, pubmed-author:LakatosPP, pubmed-author:MaironNN, pubmed-author:MillerP DPD, pubmed-author:ReginsterJ-YJY, pubmed-author:RowellLL, pubmed-author:SilvermanS LSL, pubmed-author:StepanJ JJJ
pubmed:issnType	Print
pubmed:volume	65
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	654-61
pubmed:dateRevised	2009-11-18
pubmed:meshHeading	pubmed-meshheading:16339289-Administration, Oral, pubmed-meshheading:16339289-Aged, pubmed-meshheading:16339289-Aged, 80 and over, pubmed-meshheading:16339289-Bone Density, pubmed-meshheading:16339289-Bone Density Conservation Agents, pubmed-meshheading:16339289-Diphosphonates, pubmed-meshheading:16339289-Dose-Response Relationship, Drug, pubmed-meshheading:16339289-Double-Blind Method, pubmed-meshheading:16339289-Drug Administration Schedule, pubmed-meshheading:16339289-Female, pubmed-meshheading:16339289-Femur, pubmed-meshheading:16339289-Hip Joint, pubmed-meshheading:16339289-Humans, pubmed-meshheading:16339289-Lumbar Vertebrae, pubmed-meshheading:16339289-Middle Aged, pubmed-meshheading:16339289-Osteoporosis, Postmenopausal, pubmed-meshheading:16339289-Treatment Outcome
pubmed:year	2006
pubmed:articleTitle	Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study.
pubmed:affiliation	University of Liège, Liège, Belgium. jyreginster@ulg.ac.be
pubmed:publicationType	Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study, Clinical Trial, Phase III